CompaniesByCap
BGLC
Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials

Bionexus Gene Lab Corp. Cash Flow 2018–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Operating Cash Flow-1.8M-2.1M-1.8M551,8229,161552,680-217,273-274,080
Depreciation & Amort.41,71440,611
Investing Activities
Capital Expenditure36,971226,989149,39803,162421,62112,817-39,621
Free Cash Flow-1.9M-2.3M-2.0M551,8225,999131,059-230,090-313,701
Financing Activities
Dividends Paid
Stock Buybacks

Bionexus Gene Lab Corp. Cash Flow — FAQ

Bionexus Gene Lab Corp. (BGLC) cash flow over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see BGLC's cash flow history?

The chart and table above show Bionexus Gene Lab Corp.'s cash flow by year and by quarter, including the growth rate.